Diagnostic utility of the Elecsys anti-CCP assay in patients with rheumatoid arthritis

References

• Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, et al. Rheumatic diseases in china. Arthritis Res Ther. 2008;10(1):R17.
   Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
   Web of Science ®Google Scholar
• Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43(1):155–63.
   Web of Science ®Google Scholar
• Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, et al. High diagnostic performance of elisa detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol. 2003;32(4):197–204.
   Web of Science ®Google Scholar
• Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F. Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol. 2003;30(7):1451–5.
   Web of Science ®Google Scholar
• Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the hla-drb1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005;52(11):3433–8.
   Web of Science ®Google Scholar
• Bizzaro N, Tonutti E, Tozzoli R, Villalta D. Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem. 2007;53(8):1527–33.
   Web of Science ®Google Scholar
• Kim S, Kim JH, Lee JH, Kim HS. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology (Oxford) 2010;49(3):450–7.
   Web of Science ®Google Scholar
• Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol. 2009;36(3):491–500.
   Web of Science ®Google Scholar
• Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol. 2002;29(1):68–74.
   Google Scholar
• Tampoia M, Brescia V, Fontana A, Maggiolini P, Lapadula G, Pansini N. Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: Analytical performance and clinical correlations. Clin Chim Acta. 2005;355(1–2):137–44.
   Web of Science ®Google Scholar
• Block DR, Jenkins SM, Dalenberg DA, Balsanek JG, Snyder MR, Saenger AK. Analytical and clinical comparison of anti-ccp assays with rheumatoid factor for the diagnosis of rheumatoid arthritis. Clin Chim Acta. 2012;413(11–12):1015–7.
   Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   Web of Science ®Google Scholar
• Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieude P, Grootenboer-Mignot S, et al. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis. Joint Bone Spine. 2009;76(3):248–53.
   Web of Science ®Google Scholar
• Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, et al. Igm-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):425–8.
   Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The stard statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Clin Chem. 2003;49:7–18.
   PubMed Web of Science ®Google Scholar
• van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-ccp antibodies: The past, the present and the future. Nat Rev Rheumatol. 2011;7(7): 391–8.
   Web of Science ®Google Scholar
• Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-ccp autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 2006;45(1):20–5.
   Web of Science ®Google Scholar
• Cai B, Wang L, Liu J, Feng W. Performance evaluation of elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available elisa assays in rheumatoid arthritis diagnosis. Clinical biochemistry. 2011;44(12):989–93.
   Web of Science ®Google Scholar
• Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem. 2001;47(6):1089–93.
   Web of Science ®Google Scholar
• Coenen D, Verschueren P, Westhovens R, Bossuyt X. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem. 2007;53(3):498–504.
   Web of Science ®Google Scholar
• Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808.
   Web of Science ®Google Scholar
• Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis. 2006;65(7):845–51.
   Web of Science ®Google Scholar
• Kim S, Kim JH, Lee JH, Kim HS. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology. 2010;49(3):450–7.
   Web of Science ®Google Scholar
• Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci. 2010;55(1):80–5.
   Web of Science ®Google Scholar